Literature DB >> 1292855

Repression of the E. coli lactose operon by cooperation between two individually unproductive "half-operator" sites.

M Amouyal1, B von Wilcken-Bergmann.   

Abstract

Two remote and weak lac regressor binding sites can be used jointly to repress the synthesis of beta-galactosidase in E. coli, while they cannot separately. When this result is discussed in reference to the various modes of cooperation between the sites, it supports with a new approach a model implying the simultaneous binding of lac repressor to both sites with the formation of a DNA loop. In connection with this point, we present a new strategy to detect cooperative interactions in vivo, based on the asymmetry of the DNA binding site, formally equivalent here to a half-site, heterodimerization of the protein, and influence of orientation of the sites on repression at short and long distance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1292855

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  4 in total

1.  A functional assay in Escherichia coli to detect non-assisted interaction between galactose repressor dimers.

Authors:  N Perez; M Rehault; M Amouyal
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  Homolog comparisons further reconcile in vitro and in vivo correlations of protein activities by revealing over-looked physiological factors.

Authors:  Sudheer Tungtur; Kristen M Schwingen; Joshua J Riepe; Chamitha J Weeramange; Liskin Swint-Kruse
Journal:  Protein Sci       Date:  2019-08-09       Impact factor: 6.725

3.  From adjacent activation in Escherichia coli and DNA cyclization to eukaryotic enhancers: the elements of a puzzle.

Authors:  Michèle Amouyal
Journal:  Front Genet       Date:  2014-11-03       Impact factor: 4.599

4.  Quality and position of the three lac operators of E. coli define efficiency of repression.

Authors:  S Oehler; M Amouyal; P Kolkhof; B von Wilcken-Bergmann; B Müller-Hill
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.